The EU medicine agency EMA gave the green light on Thursday to approve a corona booster vaccine from the French pharmaceutical company Sanofi. According to the EMA, it has been shown in studies to be effective against the ommicron variant of the virus.
The vaccine, jointly developed by Sanofi and the British company GlaxoSmithKline, is suitable as a booster vaccine for adults after previous vaccination with the preparations of Biontech/Pfizer, Moderna and those of AstraZeneca and Johnson&Johnson, the EMA explains.
Sanofi announced in mid-June that the booster vaccine called Vidprevtyn achieved a stronger immune response than the Biontech booster vaccine in studies of people receiving their primary immunization with the Biontech/Pfizer vaccine.
Sanofi and GSK had developed the “new generation” vaccine, which was well tolerated, along with their base vaccine, which is still pending approval.
Source: Krone
I’m Wayne Wickman, a professional journalist and author for Today Times Live. My specialty is covering global news and current events, offering readers a unique perspective on the world’s most pressing issues. I’m passionate about storytelling and helping people stay informed on the goings-on of our planet.
